Howard McLeod
Howard McLeod
Howard McLeod (pronounced: HOW-ard mə-KLOUD) is a renowned pharmacogenomics researcher and medical professional. His contributions to the field of medicine and genetics have been instrumental in the development of personalized medicine.
Etymology
The name "Howard" is of Old Norse origin, meaning "high guard". "McLeod" is a Scottish surname, derived from the Gaelic "MacLeòid", meaning "son of Leod". The name "Leod" is derived from the Old Norse name "Ljótr", meaning "ugly".
Career
Howard McLeod is best known for his work in the field of pharmacogenomics, the study of how genes affect a person's response to drugs. This relatively new field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective, safe medications and doses that will be tailored to a person's genetic makeup.
McLeod is currently the Medical Director at the DeBartolo Family Personalized Medicine Institute at the Moffitt Cancer Center. He is also a Professor at the University of South Florida.
Contributions
McLeod has made significant contributions to the understanding of how genetic variations can affect the body's response to various medications. His research has helped to pave the way for the development of personalized medicine, which aims to tailor medical treatment to the individual characteristics of each patient.
Related Terms
- Pharmacogenomics
- Genomics
- Pharmacology
- Personalized Medicine
- Moffitt Cancer Center
- University of South Florida
External links
- Medical encyclopedia article on Howard McLeod
- Wikipedia's article - Howard McLeod
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski